Covers methods for creating stable cell lines, including vector design, selection strategies, and validation procedures.
Explore microfluidic screening for function-first antibody discovery. Identify active antibodies early using single-cell droplet technology and native IgG secretion.
Over the past four decades, antibody discovery platforms have transformed biotherapeutics. Hybridoma technology, developed in 1975, pioneered the production of monoclonal antibodies, while more recent advances in single B cell screening have expanded access to rare, high-affinity clones.
CHOK1BN: A proven CHO cell line with high productivity, stability, and global compliance. License from Biointron for antibody manufacturing success.
Single-cell antibody sequencing reveals repertoire diversity. Biointron applies this method to uncover potent candidates for therapeutic antibody programs.
High-throughput single B cell screening is transforming discovery. Biointron demonstrates how advanced platforms accelerate identification of potent antibodies.
CHO cells are the gold standard for antibody production. Biointron applies codon optimization, advanced vectors, and stable expression systems to deliver high-yield recombinant antibodies.
Single B cell technology accelerates antibody discovery. Biointron demonstrates how this approach delivers potent candidates faster and with greater precision.
Plasma cells secrete vast amounts of antibodies. Biointron describes their differentiation from B cells and the importance of this process in immune defense.
B cell activation depends on complex signaling. Biointron outlines the pathways and checkpoints that regulate antibody generation and adaptive immunity.
Antigen recognition initiates immune defense. Biointron explains how B cell activation shapes antibody production and drives effective immune responses.
High-throughput antibody production changes the pace of biotech. Learn how automation and Single B Cell Screening deliver thousands of antibodies with speed and quality.
Learn how antibody screening works, including key methods like ELISA and flow cytometry, and why it is essential for developing drugs, vaccines, and diagnostic applications.
You can also contact us on the Scientist and Science Exchange marketplaces.
